TUG1 Promoted Tumor Progression by Sponging miR-335-5p and Regulating CXCR4-Mediated Infiltration of Pro-Tumor Immunocytes in CTNNB1-Mutated Hepatoblastoma

WNT/β-catenin pathway activation correlates with immune exclusion across human cancers

(2019) Jason J. Luke et al.   CLINICAL CANCER RESEARCH

Impact of CXCR4 and CXCR7 knockout by CRISPR/Cas9 on the function of triple-negative breast cancer cells

(2019) Meng Yang et al.   OncoTargets and Therapy

Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo

(2019) Jia-Hong Chen et al.   BMC CANCER

Molecular mechanisms of TUG1 in the proliferation, apoptosis, migration and invasion of cancer cells (Review)

(2019) Hui Zhou et al.   Oncology Letters

CXCR4 in human osteosarcoma malignant progression. The response of osteosarcoma cell lines to the fully human CXCR4 antibody MDX1338

(2019) Serena Pollino et al.   Journal of Bone Oncology

Comprehensive analysis and experimental verification of LINC01314 as a tumor suppressor in hepatoblastoma

(2018) Benji Lv et al.   BIOMEDICINE & PHARMACOTHERAPY

Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy

(2018) Adriana Albini et al.   Frontiers in Immunology

The Role of CXC Chemokine Receptors 1–4 on Immune Cells in the Tumor Microenvironment

(2018) Katharina Helene Susek et al.   Frontiers in Immunology

Roles of the immune system in cancer: from tumor initiation to metastatic progression

(2018) Hugo Gonzalez et al.   GENES & DEVELOPMENT

Wnt–β-catenin signalling in liver development, health and disease

(2018) Maria J. Perugorria et al.   Nature Reviews Gastroenterology & Hepatology

Comprehensive molecular and immunological characterization of hepatocellular carcinoma

(2018) Shu Shimada et al.   EBioMedicine

Unknown

(2017)   HEPATOLOGY

A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor

(2017) Samantha Gadd et al.   NATURE GENETICS

β-Catenin promotes cell proliferation, migration, and invasion but induces apoptosis in renal cell carcinoma

(2017) Chun-Ming Yang et al.   OncoTargets and Therapy

Identification of differentially expressed genes, lncRNAs and miRNAs which are associated with tumor malignant phenotypes in hepatoblastoma patients

(2017) Sida Liu et al.   Oncotarget

Unknown

(2016)   HEPATOLOGY

Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment

(2016) Valery Vilchez   WORLD JOURNAL OF GASTROENTEROLOGY

Targeting long non-coding RNA-TUG1 inhibits tumor growth and angiogenesis in hepatoblastoma

(2016) R Dong et al.   Cell Death & Disease

Transcriptional modules related to hepatocellular carcinoma survival: coexpression network analysis

(2016) Xinsen Xu et al.   Frontiers of Medicine

Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells

(2015) Chih-Cheng Hsiao et al.   CANCER LETTERS

A Micropeptide Encoded by a Putative Long Noncoding RNA Regulates Muscle Performance

(2015) Douglas M. Anderson et al.   CELL

A CXCR4 antagonist leads to tumor suppression by activation of immune cells in a leukemia-induced microenvironment

(2015) A-REUM HAN et al.   ONCOLOGY REPORTS

MicroRNAs and other non-coding RNAs as targets for anticancer drug development

(2013) Hui Ling et al.   NATURE REVIEWS DRUG DISCOVERY

Long non-coding RNAs: new players in cell differentiation and development

(2013) Alessandro Fatica et al.   NATURE REVIEWS GENETICS

Prognostic stratification for children with hepatoblastoma: The SIOPEL experience

(2012) Rudolf Maibach et al.   EUROPEAN JOURNAL OF CANCER

Activated NOTCH2 is Overexpressed in Hepatoblastomas: An Immunohistochemical Study

(2011) Jason B. Litten et al.   PEDIATRIC AND DEVELOPMENTAL PATHOLOGY